To investigate the factors that modulate the progression of osteoarthritis, we examined human synovium from OA patients and normal controls (patients with femoral fracture) and observed enhanced expression of inducible nitric oxide synthase (iNOS) and reduced expression of CD206 in the OA synovium compared to controls (Fig. 2a). The gene discussed is MRC1; the disease is osteoarthritis.